Terms: = Skin cancer AND MYD88, Q99836, MYD88D, 4615
61 results:
1. Heterocyclic-Modified Imidazoquinoline Derivatives: Selective TLR7 Agonist Regulates Tumor Microenvironment against Melanoma.
Ou J; Zheng L; Chen Y; Fu Q; Tan L; Liang E; Huang L; Pan Y; Ke J; Chen Z; Cheng K
J Med Chem; 2024 Mar; 67(5):3321-3338. PubMed ID: 38363069
[TBL] [Abstract] [Full Text] [Related]
2. Sinonasal DLBCL: molecular profiling identifies subtypes with distinctive prognosis and targetable genetic features.
Eriksen PRG; de Groot F; Clasen-Linde E; de Nully Brown P; de Groen R; Melchior LC; Maier AD; Minderman M; Vermaat JSP; von Buchwald C; Pals ST; Heegaard S
Blood Adv; 2024 Apr; 8(8):1946-1957. PubMed ID: 38324724
[TBL] [Abstract] [Full Text] [Related]
3. CD39 and LDHA affects the prognostic role of NLR in metastatic melanoma patients treated with immunotherapy.
Mallardo D; Fordellone M; White A; Ottaviano M; Sparano F; Bailey M; Facchini AB; Ong S; Maiolino P; Caracò C; Church S; Cavalcanti E; Warren S; Budillon A; Cesano A; Simeone E; Chiodini P; Ascierto PA
J Transl Med; 2023 Sep; 21(1):610. PubMed ID: 37684649
[TBL] [Abstract] [Full Text] [Related]
4. Clinicopathological, cytogenetic, and molecular profiles of primary cutaneous diffuse large B-cell lymphomas.
Uccella S; Goteri G; Maiorana A; Donati V; Tibiletti MG; Magnoli F; Facchi S; Merchiori D; Morsia E; Papotti R; Bettelli S; Forti E; Galimberti S; Rupoli S; Filosa A; Dardanis D; Bomben R; Braglia L; Pozzi S; Sacchi S
Hum Pathol; 2023 Jun; 136():44-55. PubMed ID: 36997030
[TBL] [Abstract] [Full Text] [Related]
5. Glycoside oleandrin downregulates toll-like receptor pathway genes and associated miRNAs in human melanoma cells.
Eroğlu Güneş C; Seçer Çelik F; Seçme M; Elmas L; Dodurga Y; Kurar E
Gene; 2022 Nov; 843():146805. PubMed ID: 35964872
[TBL] [Abstract] [Full Text] [Related]
6. Interleukin-33 (IL-33): A critical review of its biology and the mechanisms involved in its release as a potent extracellular cytokine.
Cayrol C; Girard JP
Cytokine; 2022 Aug; 156():155891. PubMed ID: 35640416
[TBL] [Abstract] [Full Text] [Related]
7. Rare pediatric tumors in Germany - not as rare as expected: a study based on data from the Bavarian cancer Registry and the German Childhood cancer Registry.
Achajew A; Brecht IB; Radespiel-Tröger M; Meyer M; Metzler M; Bremensdorfer C; Spix C; Erdmann F; Schneider DT; Abele M
Eur J Pediatr; 2022 Jul; 181(7):2723-2730. PubMed ID: 35478271
[TBL] [Abstract] [Full Text] [Related]
8. Costimulation of γδTCR and TLR7/8 promotes Vδ2 T-cell antitumor activity by modulating mTOR pathway and APC function.
Wang H; Chen H; Liu S; Zhang J; Lu H; Somasundaram R; Choi R; Zhang G; Ou L; Scholler J; Tian S; Dong L; Yeye G; Huang L; Connelly T; Li L; Huang A; Mitchell TC; Fan Y; June CH; Mills GB; Guo W; Herlyn M; Xu X
J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34937742
[TBL] [Abstract] [Full Text] [Related]
9. Phase 1 study of ibrutinib and the CXCR4 antagonist ulocuplumab in CXCR4-mutated Waldenström macroglobulinemia.
Treon SP; Meid K; Hunter ZR; Flynn CA; Sarosiek SR; Leventoff CR; White TP; Cao Y; Roccaro AM; Sacco A; Demos MG; Guerrera ML; Kofides A; Liu X; Xu L; Patterson CJ; Munshi M; Tsakmaklis N; Yang G; Ghobrial IM; Branagan AR; Castillo JJ
Blood; 2021 Oct; 138(17):1535-1539. PubMed ID: 34289017
[TBL] [Abstract] [Full Text] [Related]
10. Plant callus-derived shikimic acid regenerates human skin through converting human dermal fibroblasts into multipotent skin-derived precursor cells.
Kwon YW; Lee SH; Kim AR; Kim BJ; Park WS; Hur J; Jang H; Yang HM; Cho HJ; Kim HS
Stem Cell Res Ther; 2021 Jun; 12(1):346. PubMed ID: 34116724
[TBL] [Abstract] [Full Text] [Related]
11. Plasma circulating cell free messenger RNA as a potential biomarker of melanoma.
Ita MI; Wang JH; Fanning N; Kaar G; Lim C; Redmond HP
Acta Oncol; 2021 Sep; 60(9):1201-1209. PubMed ID: 34086522
[TBL] [Abstract] [Full Text] [Related]
12. A myd88/IL1R Axis Regulates PD-1 Expression on Tumor-Associated Macrophages and Sustains Their Immunosuppressive Function in Melanoma.
Tartey S; Neale G; Vogel P; Malireddi RKS; Kanneganti TD
Cancer Res; 2021 May; 81(9):2358-2372. PubMed ID: 33619117
[TBL] [Abstract] [Full Text] [Related]
13. Lymphoplasmacytic lymphoma in a patient with Birt-Hogg-Dubé syndrome.
Kurata K; Matsumoto H; Jimbo N; Yakushijin K; Yamamoto K; Ito M; Nakamachi Y; Matsuoka H; Saegusa J; Seyama K; Itoh T; Minami H
Int J Hematol; 2020 Dec; 112(6):864-870. PubMed ID: 32789566
[TBL] [Abstract] [Full Text] [Related]
14. Induction of IRAK-M in melanoma induces caspase-3 dependent apoptosis by reducing TRAF6 and calpastatin levels.
Geng D; Ciavattone N; Lasola JJ; Shrestha R; Sanchez A; Guo J; Vlk A; Younis R; Wang L; Brown AJ; Zhang Y; Velasco-Gonzalez C; Tan AC; Davila E
Commun Biol; 2020 Jun; 3(1):306. PubMed ID: 32533049
[TBL] [Abstract] [Full Text] [Related]
15. Incomplete Freund's adjuvant reduces arginase and enhances Th1 dominance, TLR signaling and CD40 ligand expression in the vaccine site microenvironment.
Pollack KE; Meneveau MO; Melssen MM; Lynch KT; Koeppel AF; Young SJ; Turner S; Kumar P; Sol-Church K; Mauldin IS; Slingluff CL
J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32350119
[TBL] [Abstract] [Full Text] [Related]
16. An unusual case of cutaneous Waldenström macroglobulinemia with the myd88 L265P mutation.
Minzenmayer AN; Miranda RN; Powell PR; Parekh PK
J Cutan Pathol; 2020 Sep; 47(9):850-853. PubMed ID: 32335928
[TBL] [Abstract] [Full Text] [Related]
17. Activation of STAT3 is a key event in TLR4 signaling-mediated melanoma progression.
Fu XQ; Liu B; Wang YP; Li JK; Zhu PL; Li T; Tse KW; Chou JY; Yin CL; Bai JX; Liu YX; Chen YJ; Yu ZL
Cell Death Dis; 2020 Apr; 11(4):246. PubMed ID: 32312954
[TBL] [Abstract] [Full Text] [Related]
18. Ginseng-derived nanoparticles alter macrophage polarization to inhibit melanoma growth.
Cao M; Yan H; Han X; Weng L; Wei Q; Sun X; Lu W; Wei Q; Ye J; Cai X; Hu C; Yin X; Cao P
J Immunother Cancer; 2019 Nov; 7(1):326. PubMed ID: 31775862
[TBL] [Abstract] [Full Text] [Related]
19. Class-switched Primary Cutaneous Marginal Zone Lymphomas Are Frequently IgG4-positive and Have Features Distinct From IgM-positive Cases.
Carlsen ED; Swerdlow SH; Cook JR; Gibson SE
Am J Surg Pathol; 2019 Oct; 43(10):1403-1412. PubMed ID: 31464711
[TBL] [Abstract] [Full Text] [Related]
20. cancer cell-derived long pentraxin 3 (PTX3) promotes melanoma migration through a toll-like receptor 4 (TLR4)/NF-κB signaling pathway.
Rathore M; Girard C; Ohanna M; Tichet M; Ben Jouira R; Garcia E; Larbret F; Gesson M; Audebert S; Lacour JP; Montaudié H; Prod'Homme V; Tartare-Deckert S; Deckert M
Oncogene; 2019 Jul; 38(30):5873-5889. PubMed ID: 31253871
[TBL] [Abstract] [Full Text] [Related]
[Next]
